The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

Williams will present on quantum technologies at The Economist’s Commercialising Quantum conference and the Quantum Tech Congress.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Fu brings expertise in identifying defects in quantum materials to the PNNL.

The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

Researchers have discovered a news way to control the quantum behavior of semiconductor materials with laser light. The discovery could lead to a new kind of quantum material.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Dr. Joseph Williams explained the importance of quantum technologies in space at the University of Washington.

Focused research studies of advanced algorithms and materials are setting the stage for the next generation of quantum computers.

Quantum simulators help navigate noise on GPU-based HPC systems.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

PNNL researchers utilized the Peeters-Devreese-Soldatov formulation to improve the accuracy of calculations for quantum chemistry.

The eighth Arab-American Frontiers of Science, Engineering, and Medicine Symposium, co-organized by PNNL engineer and research line manager Leonard Pease, brought together multi-disciplinary researchers from around the globe.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.